Tate & Lyle Launches Beverage OPTIMIZE™ Formulation Service in North America

| Filed in:

Chicago – (April 6, 2012) – Tate & Lyle, the global provider of specialty food ingredients, announces the launch of its new Beverage OPTIMIZE™ formulation service in the U.S. Through Beverage OPTIMIZE™, food and beverage manufacturers can work directly with Tate & Lyle to reduce calories using the company’s extensive beverage formulation experience and wide portfolio of ingredients including sweeteners such as SPLENDA® Sucralose and KRYSTAR® Crystalline Fructose, as well as texturants and acidulants.

With rising commodity prices affecting manufacturing costs, the new formulation service offers companies a consistent way to manage sweetener costs and reduce margin pressure in existing products, line extensions and new product launches.

Tate & Lyle has developed a variety of new prototypes to showcase the great-tasting sugar reduction capabilities of the Beverage OPTIMIZE™ service for customers. Prototypes are now available in the following categories: juices, carbonated soft drinks, still drinks and beverage mixes.

“Beverage OPTIMIZE™ offers our customers a way to work directly with our formulations experts to develop a great-tasting beverage with the additional benefits of a strong opportunity nutrition label improvements for those who desire them,” said Pashen Black, Americas Marketing Manager, Tate & Lyle.

To ensure success at every level, Tate & Lyle’s formulation experts will work on-site with customers on their specific needs at every stage of development and manufacturing, driving innovation from the lab to the line.

“Our team employs a customized approach for every customer to leverage our ingredient interactions and synergies for each individual beverage product,” said Joni Simms, Director, Technical Services, Tate & Lyle.

To request prototype samples please contact your Tate & Lyle sales representative or email [email protected].

About Tate & Lyle

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, operating from over 30 production facilities around the world.

Tate & Lyle operates through two global business units, Specialty Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Specialty Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.

Specialty Food Ingredients include starch-based specialty ingredients (corn-based specialty starches, sweeteners and fibers), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2011, Tate & Lyle sales totaled £2.7 billion. http://www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC.


Click here for our press image gallery

About Tate & Lyle: 
Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, fortification, and texture, we develop ingredient solutions which reduce sugar, calories, and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.

We have more than 3,500 employees working in around 57 locations across 39 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives Through the Science of Food. By living our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2023, Tate & Lyle revenue from continuing operations totalled £1.75 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on TwitterLinkedinFacebook or YouTube